Table 1 hsa-mir-4551 targets prediction results ,,,,
targets ID,taegets,name,,
ENSG00000115966,ATF2,activating transcription factor 2(ATF2),,
ENSG00000100422,CERK,ceramide kinase(CERK),,
ENSG00000139990,DCAF5,DDB1 and CUL4 associated factor 5(DCAF5),,
ENSG00000165046,LETM2,leucine zipper and EF-hand containing transmembrane protein 2(LETM2),,
ENSG00000161921,CXCL16,C-X-C motif chemokine ligand 16(CXCL16),,
ENSG00000166436,TRIM66,tripartite motif containing 66(TRIM66),,
ENSG00000109189,USP46,ubiquitin specific peptidase 46(USP46),,
ENSG00000104142,VPS18,"VPS18, CORVET/HOPS core subunit(VPS18)",,
ENSG00000182831,C16orf72,chromosome 16 open reading frame 72(C16orf72),,
ENSG00000166971,AKTIP,AKT interacting protein(AKTIP),,
ENSG00000143867,OSR1,odd-skipped related transciption factor 1(OSR1),,
ENSG00000165699,TSC1,tuberous sclerosis 1(TSC1),,
ENSG00000240972,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor)(MIF),,
ENSG00000164924,YWHAZ,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta(YWHAZ),,
ENSG00000120549,KIAA1217,KIAA1217(KIAA1217),,
ENSG00000129933,MAU2,MAU2 sister chromatid cohesion factor(MAU2),,
ENSG00000139154,AEBP2,AE binding protein 2(AEBP2),,
ENSG00000196405,EVL,Enah/Vasp-like(EVL),,
ENSG00000126464,PRR12,proline rich 12(PRR12),,
ENSG00000162591,MEGF6,multiple EGF like domains 6(MEGF6),,
ENSG00000197226,TBC1D9B,TBC1 domain family member 9B(TBC1D9B),,
ENSG00000108671,PSMD11,"proteasome 26S subunit, non-ATPase 11(PSMD11)",,
ENSG00000055070,SZRD1,SUZ RNA binding domain containing 1(SZRD1),,
ENSG00000085563,ABCB1,ATP binding cassette subfamily B member 1(ABCB1),,
ENSG00000135932,CAB39,calcium binding protein 39(CAB39),,
ENSG00000187398,LUZP2,leucine zipper protein 2(LUZP2),,
ENSG00000163637,PRICKLE2,prickle planar cell polarity protein 2(PRICKLE2),,
ENSG00000111859,NEDD9,"neural precursor cell expressed, developmentally down-regulated 9(NEDD9)",,
ENSG00000211689,TARP,TCR gamma alternate reading frame protein(TARP),,
ENSG00000140092,FBLN5,fibulin 5(FBLN5),,
ENSG00000155657,TTN,titin(TTN),,
ENSG00000148468,FAM171A1,family with sequence similarity 171 member A1(FAM171A1),,
ENSG00000111249,CUX2,cut like homeobox 2(CUX2),,
ENSG00000146373,RNF217,ring finger protein 217(RNF217),,
ENSG00000113532,ST8SIA4,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4(ST8SIA4)",,
ENSG00000267534,S1PR2,sphingosine-1-phosphate receptor 2(S1PR2),,
ENSG00000116604,MEF2D,myocyte enhancer factor 2D(MEF2D),,
ENSG00000129355,CDKN2D,cyclin dependent kinase inhibitor 2D(CDKN2D),,
ENSG00000184058,TBX1,T-box 1(TBX1),,
ENSG00000147883,CDKN2B,cyclin dependent kinase inhibitor 2B(CDKN2B),,
ENSG00000198814,GK,glycerol kinase(GK),,
ENSG00000105974,CAV1,caveolin 1(CAV1),,
ENSG00000091317,CMTM6,CKLF like MARVEL transmembrane domain containing 6(CMTM6),,
ENSG00000140650,PMM2,phosphomannomutase 2(PMM2),,
ENSG00000172071,EIF2AK3,eukaryotic translation initiation factor 2 alpha kinase 3(EIF2AK3),,
ENSG00000179134,SAMD4B,sterile alpha motif domain containing 4B(SAMD4B),,
ENSG00000183826,BTBD9,BTB domain containing 9(BTBD9),,
ENSG00000165355,FBXO33,F-box protein 33(FBXO33),,
ENSG00000176624,MEX3C,mex-3 RNA binding family member C(MEX3C),,
ENSG00000204264,PSMB8,proteasome subunit beta 8(PSMB8),,
ENSG00000143614,GATAD2B,GATA zinc finger domain containing 2B(GATAD2B),,
ENSG00000130717,UCK1,uridine-cytidine kinase 1(UCK1),,
ENSG00000101558,VAPA,VAMP associated protein A(VAPA),,
ENSG00000158966,CACHD1,cache domain containing 1(CACHD1),,
ENSG00000144566,RAB5A,"RAB5A, member RAS oncogene family(RAB5A)",,
,,,,
,,,,
Table 2 GO enrichment results,,,,
Ontology,GO ID,GO term,P-value,
BP,GO:2000286,receptor internalization involved in canonical Wnt signaling pathway,0.00002,
BP,GO:0016310,phosphorylation,0.00002,
BP,GO:0045859,regulation of protein kinase activity,0.00017,
BP,GO:0002062,chondrocyte differentiation,0.00022,
BP,GO:0001932,regulation of protein phosphorylation,0.00024,
BP,GO:0009887,animal organ morphogenesis,0.00025,
BP,GO:0006464,cellular protein modification process,0.0003,
BP,GO:0036211,protein modification process,0.0003,
BP,GO:0043549,regulation of kinase activity,0.00033,
BP,GO:0006468,protein phosphorylation,0.00037,
BP,GO:0006796,phosphate-containing compound metabolic process,0.00042,
BP,GO:0006793,phosphorus metabolic process,0.00047,
BP,GO:0060537,muscle tissue development,0.00053,
BP,GO:0042325,regulation of phosphorylation,0.00056,
BP,GO:0061448,connective tissue development,0.00057,
BP,GO:0043412,macromolecule modification,0.00063,
BP,GO:0010629,negative regulation of gene expression,0.00069,
BP,GO:0051338,regulation of transferase activity,0.00072,
BP,GO:0051179,localization,0.00084,
BP,GO:2001242,regulation of intrinsic apoptotic signaling pathway,0.00088,
BP,GO:0032413,negative regulation of ion transmembrane transporter activity,0.00094,
BP,GO:1905114,cell surface receptor signaling pathway involved in cell-cell signaling,0.00098,
BP,GO:0009628,response to abiotic stimulus,0.00103,
BP,GO:0042474,middle ear morphogenesis,0.00105,
BP,GO:0065009,regulation of molecular function,0.00106,
BP,GO:0016192,vesicle-mediated transport,0.00115,
BP,GO:0045055,regulated exocytosis,0.00127,
BP,GO:0031323,regulation of cellular metabolic process,0.00132,
BP,GO:0006970,response to osmotic stress,0.00137,
BP,GO:0032410,negative regulation of transporter activity,0.00137,
BP,GO:0043488,regulation of mRNA stability,0.00137,
BP,GO:1904063,negative regulation of cation transmembrane transport,0.00141,
BP,GO:0044093,positive regulation of molecular function,0.00156,
BP,GO:0031329,regulation of cellular catabolic process,0.0016,
BP,GO:0045786,negative regulation of cell cycle,0.00161,
BP,GO:0044070,regulation of anion transport,0.00164,
BP,GO:0019220,regulation of phosphate metabolic process,0.00164,
BP,GO:0051174,regulation of phosphorus metabolic process,0.00166,
BP,GO:0048729,tissue morphogenesis,0.00167,
BP,GO:0043487,regulation of RNA stability,0.00167,
BP,GO:0099003,vesicle-mediated transport in synapse,0.00167,
BP,GO:0006810,transport,0.00168,
BP,GO:0009888,tissue development,0.00169,
BP,GO:0071900,regulation of protein serine/threonine kinase activity,0.00175,
BP,GO:0031645,negative regulation of neurological system process,0.00177,
BP,GO:0097186,amelogenesis,0.00177,
BP,GO:1903959,regulation of anion transmembrane transport,0.00177,
BP,GO:1903047,mitotic cell cycle process,0.00181,
BP,GO:0001501,skeletal system development,0.00182,
BP,GO:0051216,cartilage development,0.00182,
BP,GO:0090630,activation of GTPase activity,0.0019,
BP,GO:0034766,negative regulation of ion transmembrane transport,0.002,
BP,GO:0061013,regulation of mRNA catabolic process,0.00201,
BP,GO:0031399,regulation of protein modification process,0.00218,
BP,GO:1901017,negative regulation of potassium ion transmembrane transporter activity,0.00221,
BP,GO:0045930,negative regulation of mitotic cell cycle,0.00225,
BP,GO:0050678,regulation of epithelial cell proliferation,0.00228,
BP,GO:0007049,cell cycle,0.00229,
BP,GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,0.00229,
BP,GO:0051234,establishment of localization,0.00232,
BP,GO:0010800,positive regulation of peptidyl-threonine phosphorylation,0.00236,
BP,GO:0008039,synaptic target recognition,0.0024,
BP,GO:0060734,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,0.0024,
BP,GO:0061078,positive regulation of prostaglandin secretion involved in immune response,0.0024,
BP,GO:0072165,anterior mesonephric tubule development,0.0024,
BP,GO:0072167,specification of mesonephric tubule identity,0.0024,
BP,GO:0072168,specification of anterior mesonephric tubule identity,0.0024,
BP,GO:0072169,specification of posterior mesonephric tubule identity,0.0024,
BP,GO:0072184,renal vesicle progenitor cell differentiation,0.0024,
BP,GO:0072258,metanephric interstitial fibroblast differentiation,0.0024,
BP,GO:0072259,metanephric interstitial fibroblast development,0.0024,
BP,GO:0090323,prostaglandin secretion involved in immune response,0.0024,
BP,GO:1900085,negative regulation of peptidyl-tyrosine autophosphorylation,0.0024,
BP,GO:0010605,negative regulation of macromolecule metabolic process,0.00249,
BP,GO:0050793,regulation of developmental process,0.0026,
BP,GO:0098693,regulation of synaptic vesicle cycle,0.00267,
BP,GO:1900027,regulation of ruffle assembly,0.00268,
BP,GO:0022402,cell cycle process,0.00274,
BP,GO:0032526,response to retinoic acid,0.0028,
BP,GO:0006887,exocytosis,0.00281,
BP,GO:0007507,heart development,0.00285,
BP,GO:0010737,protein kinase A signaling,0.00285,
BP,GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,0.00285,
BP,GO:1901380,negative regulation of potassium ion transmembrane transport,0.00285,
BP,GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,0.00285,
BP,GO:0031623,receptor internalization,0.00294,
BP,GO:0014706,striated muscle tissue development,0.00299,
BP,GO:1904030,negative regulation of cyclin-dependent protein kinase activity,0.00302,
BP,GO:0010948,negative regulation of cell cycle process,0.00315,
BP,GO:0009894,regulation of catabolic process,0.00344,
BP,GO:0007050,cell cycle arrest,0.00349,
BP,GO:0060071,"Wnt signaling pathway, planar cell polarity pathway",0.00353,
BP,GO:0071453,cellular response to oxygen levels,0.00354,
BP,GO:0008104,protein localization,0.00356,
BP,GO:1901890,positive regulation of cell junction assembly,0.00357,
BP,GO:0032412,regulation of ion transmembrane transporter activity,0.00359,
BP,GO:0090175,regulation of establishment of planar polarity,0.00369,
BP,GO:0044267,cellular protein metabolic process,0.00373,
BP,GO:0034763,negative regulation of transmembrane transport,0.00377,
BP,GO:0048706,embryonic skeletal system development,0.00377,
BP,GO:0042476,odontogenesis,0.00385,
BP,GO:0032879,regulation of localization,0.00395,
BP,GO:0045022,early endosome to late endosome transport,0.00396,
BP,GO:0022898,regulation of transmembrane transporter activity,0.00399,
BP,GO:2000113,negative regulation of cellular macromolecule biosynthetic process,0.004,
BP,GO:2001233,regulation of apoptotic signaling pathway,0.00407,
BP,GO:0050673,epithelial cell proliferation,0.00411,
BP,GO:0051259,protein complex oligomerization,0.00418,
BP,GO:0033036,macromolecule localization,0.00434,
BP,GO:0043267,negative regulation of potassium ion transport,0.00437,
BP,GO:0000278,mitotic cell cycle,0.00443,
BP,GO:1901991,negative regulation of mitotic cell cycle phase transition,0.00449,
BP,GO:0098927,vesicle-mediated transport between endosomal compartments,0.00459,
BP,GO:1902229,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,0.00459,
BP,GO:0048863,stem cell differentiation,0.0046,
BP,GO:2000027,regulation of animal organ morphogenesis,0.00466,
BP,GO:0051641,cellular localization,0.00468,
BP,GO:0010256,endomembrane system organization,0.00473,
BP,GO:0021644,vagus nerve morphogenesis,0.0048,
BP,GO:0032915,positive regulation of transforming growth factor beta2 production,0.0048,
BP,GO:0035981,tongue muscle cell differentiation,0.0048,
BP,GO:0048389,intermediate mesoderm development,0.0048,
BP,GO:0061227,pattern specification involved in mesonephros development,0.0048,
BP,GO:0072071,kidney interstitial fibroblast differentiation,0.0048,
BP,GO:0072098,anterior/posterior pattern specification involved in kidney development,0.0048,
BP,GO:0072141,renal interstitial fibroblast development,0.0048,
BP,GO:0072166,posterior mesonephric tubule development,0.0048,
BP,GO:0072183,negative regulation of nephron tubule epithelial cell differentiation,0.0048,
BP,GO:0072185,metanephric cap development,0.0048,
BP,GO:0072186,metanephric cap morphogenesis,0.0048,
BP,GO:0072208,metanephric smooth muscle tissue development,0.0048,
BP,GO:0086098,angiotensin-activated signaling pathway involved in heart process,0.0048,
BP,GO:0090094,metanephric cap mesenchymal cell proliferation involved in metanephros development,0.0048,
BP,GO:0099040,ceramide translocation,0.0048,
BP,GO:1905407,regulation of creatine transmembrane transporter activity,0.0048,
BP,GO:1905408,negative regulation of creatine transmembrane transporter activity,0.0048,
BP,GO:2001035,regulation of tongue muscle cell differentiation,0.0048,
BP,GO:2001037,positive regulation of tongue muscle cell differentiation,0.0048,
BP,GO:0031644,regulation of neurological system process,0.00483,
BP,GO:0032409,regulation of transporter activity,0.00484,
BP,GO:0016043,cellular component organization,0.00488,
BP,GO:0000086,G2/M transition of mitotic cell cycle,0.00496,
BP,GO:0001736,establishment of planar polarity,0.00502,
BP,GO:0007164,establishment of tissue polarity,0.00502,
BP,GO:0010608,posttranscriptional regulation of gene expression,0.00508,
BP,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,0.00509,
BP,GO:0050804,modulation of chemical synaptic transmission,0.00523,
BP,GO:0009892,negative regulation of metabolic process,0.00528,
BP,GO:0099177,regulation of trans-synaptic signaling,0.00528,
BP,GO:0010463,mesenchymal cell proliferation,0.00548,
BP,GO:0098815,modulation of excitatory postsynaptic potential,0.00548,
BP,GO:0071901,negative regulation of protein serine/threonine kinase activity,0.00562,
BP,GO:1901988,negative regulation of cell cycle phase transition,0.00566,
BP,GO:0018105,peptidyl-serine phosphorylation,0.00586,
BP,GO:0010558,negative regulation of macromolecule biosynthetic process,0.00587,
BP,GO:0002063,chondrocyte development,0.00595,
BP,GO:0010799,regulation of peptidyl-threonine phosphorylation,0.00595,
BP,GO:0030534,adult behavior,0.00604,
BP,GO:0044839,cell cycle G2/M phase transition,0.00613,
BP,GO:0006511,ubiquitin-dependent protein catabolic process,0.00625,
BP,GO:0048468,cell development,0.00627,
BP,GO:0032268,regulation of cellular protein metabolic process,0.0063,
BP,GO:0034613,cellular protein localization,0.00642,
BP,GO:0097178,ruffle assembly,0.00645,
BP,GO:2000026,regulation of multicellular organismal development,0.00647,
BP,GO:0030100,regulation of endocytosis,0.00649,
BP,GO:0019941,modification-dependent protein catabolic process,0.00651,
BP,GO:0060341,regulation of cellular localization,0.00654,
BP,GO:0044237,cellular metabolic process,0.00657,
BP,GO:0051246,regulation of protein metabolic process,0.00658,
BP,GO:0009653,anatomical structure morphogenesis,0.00662,
BP,GO:0097193,intrinsic apoptotic signaling pathway,0.00671,
BP,GO:0001738,morphogenesis of a polarized epithelium,0.00671,
BP,GO:0070727,cellular macromolecule localization,0.00672,
BP,GO:0048522,positive regulation of cellular process,0.00681,
BP,GO:0019222,regulation of metabolic process,0.0069,
BP,GO:1903793,positive regulation of anion transport,0.00696,
BP,GO:0043632,modification-dependent macromolecule catabolic process,0.00701,
BP,GO:0090263,positive regulation of canonical Wnt signaling pathway,0.00707,
BP,GO:0006407,rRNA export from nucleus,0.0072,
BP,GO:0019065,receptor-mediated endocytosis of virus by host cell,0.0072,
BP,GO:0021564,vagus nerve development,0.0072,
BP,GO:0033484,nitric oxide homeostasis,0.0072,
BP,GO:0036022,limb joint morphogenesis,0.0072,
BP,GO:0036023,embryonic skeletal limb joint morphogenesis,0.0072,
BP,GO:0044211,CTP salvage,0.0072,
BP,GO:0048769,sarcomerogenesis,0.0072,
BP,GO:0072190,ureter urothelium development,0.0072,
BP,GO:0072194,kidney smooth muscle tissue development,0.0072,
BP,GO:0075509,endocytosis involved in viral entry into host cell,0.0072,
BP,GO:0110024,positive regulation of cardiac muscle myoblast proliferation,0.0072,
BP,GO:1902811,positive regulation of skeletal muscle fiber differentiation,0.0072,
BP,GO:1903598,positive regulation of gap junction assembly,0.0072,
BP,GO:1990737,response to manganese-induced endoplasmic reticulum stress,0.0072,
BP,GO:0030856,regulation of epithelial cell differentiation,0.00731,
BP,GO:0071840,cellular component organization or biogenesis,0.00733,
BP,GO:0072359,circulatory system development,0.00745,
BP,GO:0030857,negative regulation of epithelial cell differentiation,0.00748,
BP,GO:0031214,biomineral tissue development,0.00755,
BP,GO:0043271,negative regulation of ion transport,0.00755,
BP,GO:0018209,peptidyl-serine modification,0.00756,
BP,GO:0007033,vacuole organization,0.00768,
BP,GO:0050680,negative regulation of epithelial cell proliferation,0.00768,
BP,GO:0031327,negative regulation of cellular biosynthetic process,0.00773,
BP,GO:0051017,actin filament bundle assembly,0.0078,
BP,GO:0051049,regulation of transport,0.00792,
BP,GO:0035567,non-canonical Wnt signaling pathway,0.00793,
BP,GO:0051496,positive regulation of stress fiber assembly,0.00803,
BP,GO:0010498,proteasomal protein catabolic process,0.00814,
BP,GO:0061572,actin filament bundle organization,0.00832,
BP,GO:0007519,skeletal muscle tissue development,0.00845,
BP,GO:0009890,negative regulation of biosynthetic process,0.00845,
BP,GO:0022603,regulation of anatomical structure morphogenesis,0.00847,
BP,GO:0051172,negative regulation of nitrogen compound metabolic process,0.00856,
BP,GO:0051649,establishment of localization in cell,0.00886,
BP,GO:0008333,endosome to lysosome transport,0.00888,
BP,GO:0051128,regulation of cellular component organization,0.0091,
BP,GO:0007040,lysosome organization,0.00917,
BP,GO:0046847,filopodium assembly,0.00917,
BP,GO:0080171,lytic vacuole organization,0.00917,
BP,GO:0022607,cellular component assembly,0.0092,
BP,GO:0006665,sphingolipid metabolic process,0.00941,
BP,GO:0031529,ruffle organization,0.00947,
BP,GO:0032890,regulation of organic acid transport,0.00947,
BP,GO:0002901,mature B cell apoptotic process,0.00959,
BP,GO:0002905,regulation of mature B cell apoptotic process,0.00959,
BP,GO:0002906,negative regulation of mature B cell apoptotic process,0.00959,
BP,GO:0003415,chondrocyte hypertrophy,0.00959,
BP,GO:0009298,GDP-mannose biosynthetic process,0.00959,
BP,GO:0032057,negative regulation of translational initiation in response to stress,0.00959,
BP,GO:0035995,detection of muscle stretch,0.00959,
BP,GO:0044860,protein localization to plasma membrane raft,0.00959,
BP,GO:0046167,glycerol-3-phosphate biosynthetic process,0.00959,
BP,GO:0070836,caveola assembly,0.00959,
BP,GO:0072131,kidney mesenchyme morphogenesis,0.00959,
BP,GO:0072133,metanephric mesenchyme morphogenesis,0.00959,
BP,GO:0072180,mesonephric duct morphogenesis,0.00959,
BP,GO:0072268,pattern specification involved in metanephros development,0.00959,
BP,GO:0090168,Golgi reassembly,0.00959,
BP,GO:0099039,sphingolipid translocation,0.00959,
BP,GO:1901529,positive regulation of anion channel activity,0.00959,
BP,GO:1902809,regulation of skeletal muscle fiber differentiation,0.00959,
BP,GO:1903596,regulation of gap junction assembly,0.00959,
BP,GO:1903609,negative regulation of inward rectifier potassium channel activity,0.00959,
BP,GO:0010646,regulation of cell communication,0.00964,
BP,GO:0060538,skeletal muscle organ development,0.00969,
BP,GO:0009967,positive regulation of signal transduction,0.00976,
BP,GO:0016050,vesicle organization,0.00986,
BP,GO:0120032,regulation of plasma membrane bounded cell projection assembly,0.00998,
BP,GO:0061024,membrane organization,0.01014,
BP,GO:0016055,Wnt signaling pathway,0.01022,
BP,GO:0060491,regulation of cell projection assembly,0.01027,
BP,GO:1901564,organonitrogen compound metabolic process,0.01031,
BP,GO:0065008,regulation of biological quality,0.01036,
BP,GO:0198738,cell-cell signaling by wnt,0.01037,
BP,GO:0051099,positive regulation of binding,0.01057,
BP,GO:0051171,regulation of nitrogen compound metabolic process,0.01062,
BP,GO:0044265,cellular macromolecule catabolic process,0.01074,
BP,GO:0060070,canonical Wnt signaling pathway,0.01075,
BP,GO:0023051,regulation of signaling,0.01089,
BP,GO:0032233,positive regulation of actin filament bundle assembly,0.01101,
BP,GO:0048869,cellular developmental process,0.01105,
BP,GO:0001101,response to acid chemical,0.01105,
BP,GO:1903311,regulation of mRNA metabolic process,0.01105,
BP,GO:0060255,regulation of macromolecule metabolic process,0.01113,
BP,GO:1901016,regulation of potassium ion transmembrane transporter activity,0.01134,
BP,GO:0030177,positive regulation of Wnt signaling pathway,0.01135,
BP,GO:0051603,proteolysis involved in cellular protein catabolic process,0.0115,
BP,GO:0030029,actin filament-based process,0.0117,
BP,GO:0010565,regulation of cellular ketone metabolic process,0.01182,
BP,GO:0060627,regulation of vesicle-mediated transport,0.01187,
BP,GO:0010138,pyrimidine ribonucleotide salvage,0.01197,
BP,GO:0044206,UMP salvage,0.01197,
BP,GO:0048550,negative regulation of pinocytosis,0.01197,
BP,GO:0072047,proximal/distal pattern formation involved in nephron development,0.01197,
BP,GO:0072081,specification of nephron tubule identity,0.01197,
BP,GO:0072162,metanephric mesenchymal cell differentiation,0.01197,
BP,GO:1900028,negative regulation of ruffle assembly,0.01197,
BP,GO:1901552,positive regulation of endothelial cell development,0.01197,
BP,GO:1903142,positive regulation of establishment of endothelial barrier,0.01197,
BP,GO:2000697,negative regulation of epithelial cell differentiation involved in kidney development,0.01197,
BP,GO:0043312,neutrophil degranulation,0.01221,
BP,GO:0023014,signal transduction by protein phosphorylation,0.01231,
BP,GO:0099504,synaptic vesicle cycle,0.01231,
BP,GO:0036465,synaptic vesicle recycling,0.01232,
BP,GO:1902110,positive regulation of mitochondrial membrane permeability involved in apoptotic process,0.01232,
BP,GO:0042127,regulation of cell proliferation,0.01236,
BP,GO:0046903,secretion,0.01244,
BP,GO:0090090,negative regulation of canonical Wnt signaling pathway,0.01248,
BP,GO:0035914,skeletal muscle cell differentiation,0.01266,
BP,GO:0002009,morphogenesis of an epithelium,0.01272,
BP,GO:0002283,neutrophil activation involved in immune response,0.01272,
BP,GO:0018193,peptidyl-amino acid modification,0.01283,
BP,GO:0008219,cell death,0.013,
BP,GO:1902686,mitochondrial outer membrane permeabilization involved in programmed cell death,0.013,
BP,GO:0001505,regulation of neurotransmitter levels,0.01302,
BP,GO:0002366,leukocyte activation involved in immune response,0.01303,
BP,GO:0031032,actomyosin structure organization,0.01315,
BP,GO:0019058,viral life cycle,0.01325,
BP,GO:0002263,cell activation involved in immune response,0.01332,
BP,GO:0043112,receptor metabolic process,0.01333,
BP,GO:1905330,regulation of morphogenesis of an epithelium,0.01333,
BP,GO:0002446,neutrophil mediated immunity,0.01343,
BP,GO:0035794,positive regulation of mitochondrial membrane permeability,0.0137,
BP,GO:0044260,cellular macromolecule metabolic process,0.01376,
BP,GO:0051726,regulation of cell cycle,0.01378,
BP,GO:0042119,neutrophil activation,0.01379,
BP,GO:0044248,cellular catabolic process,0.01385,
BP,GO:0031324,negative regulation of cellular metabolic process,0.01388,
BP,GO:0071300,cellular response to retinoic acid,0.01405,
BP,GO:0018108,peptidyl-tyrosine phosphorylation,0.01408,
BP,GO:0010035,response to inorganic substance,0.01416,
BP,GO:0003057,regulation of the force of heart contraction by chemical signal,0.01434,
BP,GO:0032262,pyrimidine nucleotide salvage,0.01434,
BP,GO:0036492,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,0.01434,
BP,GO:0044789,modulation by host of viral release from host cell,0.01434,
BP,GO:0044791,positive regulation by host of viral release from host cell,0.01434,
BP,GO:0051029,rRNA transport,0.01434,
BP,GO:0051036,regulation of endosome size,0.01434,
BP,GO:0071921,cohesin loading,0.01434,
BP,GO:0072143,mesangial cell development,0.01434,
BP,GO:0098528,skeletal muscle fiber differentiation,0.01434,
BP,GO:0110021,cardiac muscle myoblast proliferation,0.01434,
BP,GO:0110022,regulation of cardiac muscle myoblast proliferation,0.01434,
BP,GO:1900084,regulation of peptidyl-tyrosine autophosphorylation,0.01434,
BP,GO:0001934,positive regulation of protein phosphorylation,0.0144,
BP,GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,0.01441,
BP,GO:0018212,peptidyl-tyrosine modification,0.01445,
BP,GO:0043687,post-translational protein modification,0.01445,
BP,GO:0036230,granulocyte activation,0.01464,
BP,GO:0006687,glycosphingolipid metabolic process,0.01477,
BP,GO:1905710,positive regulation of membrane permeability,0.01477,
BP,GO:0080090,regulation of primary metabolic process,0.0148,
BP,GO:0051260,protein homooligomerization,0.01482,
BP,GO:0050790,regulation of catalytic activity,0.01495,
BP,GO:0030154,cell differentiation,0.01495,
BP,GO:0036293,response to decreased oxygen levels,0.01507,
BP,GO:0080135,regulation of cellular response to stress,0.01526,
BP,GO:0044257,cellular protein catabolic process,0.0155,
BP,GO:0003151,outflow tract morphogenesis,0.01551,
BP,GO:2000300,regulation of synaptic vesicle exocytosis,0.01551,
BP,GO:0009893,positive regulation of metabolic process,0.01551,
BP,GO:0048523,negative regulation of cellular process,0.01598,
BP,GO:0006521,regulation of cellular amino acid metabolic process,0.01664,
BP,GO:0017148,negative regulation of translation,0.01665,
BP,GO:0019563,glycerol catabolic process,0.01672,
BP,GO:0031642,negative regulation of myelination,0.01672,
BP,GO:0032055,negative regulation of translation in response to stress,0.01672,
BP,GO:0036491,regulation of translation initiation in response to endoplasmic reticulum stress,0.01672,
BP,GO:0044829,positive regulation by host of viral genome replication,0.01672,
BP,GO:0048752,semicircular canal morphogenesis,0.01672,
BP,GO:0060017,parathyroid gland development,0.01672,
BP,GO:0071455,cellular response to hyperoxia,0.01672,
BP,GO:0072007,mesangial cell differentiation,0.01672,
BP,GO:0090238,positive regulation of arachidonic acid secretion,0.01672,
BP,GO:0150093,amyloid-beta clearance by transcytosis,0.01672,
BP,GO:1901979,regulation of inward rectifier potassium channel activity,0.01672,
BP,GO:1903071,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,0.01672,
BP,GO:2000535,regulation of entry of bacterium into host cell,0.01672,
BP,GO:0006898,receptor-mediated endocytosis,0.0169,
BP,GO:0007610,behavior,0.01695,
BP,GO:0033554,cellular response to stress,0.01696,
BP,GO:0008344,adult locomotory behavior,0.01703,
BP,GO:0051093,negative regulation of developmental process,0.01704,
BP,GO:0010604,positive regulation of macromolecule metabolic process,0.01713,
BP,GO:0007032,endosome organization,0.01742,
BP,GO:0060415,muscle tissue morphogenesis,0.01742,
BP,GO:1902803,regulation of synaptic vesicle transport,0.01742,
BP,GO:0044085,cellular component biogenesis,0.01742,
BP,GO:0043299,leukocyte degranulation,0.01748,
BP,GO:0044772,mitotic cell cycle phase transition,0.01759,
BP,GO:0060429,epithelium development,0.01763,
BP,GO:0030178,negative regulation of Wnt signaling pathway,0.01765,
BP,GO:0042886,amide transport,0.01769,
BP,GO:0008283,cell proliferation,0.0178,
BP,GO:0010647,positive regulation of cell communication,0.01791,
BP,GO:0000122,negative regulation of transcription by RNA polymerase II,0.01792,
BP,GO:0006643,membrane lipid metabolic process,0.01805,
BP,GO:0046902,regulation of mitochondrial membrane permeability,0.01821,
BP,GO:0070482,response to oxygen levels,0.01829,
BP,GO:0002275,myeloid cell activation involved in immune response,0.01835,
BP,GO:0042327,positive regulation of phosphorylation,0.01837,
BP,GO:0023056,positive regulation of signaling,0.01838,
BP,GO:0071705,nitrogen compound transport,0.01843,
BP,GO:0060548,negative regulation of cell death,0.01901,
BP,GO:0048518,positive regulation of biological process,0.01907,
BP,GO:0019405,alditol catabolic process,0.01908,
BP,GO:0031666,positive regulation of lipopolysaccharide-mediated signaling pathway,0.01908,
BP,GO:0032906,transforming growth factor beta2 production,0.01908,
BP,GO:0032909,regulation of transforming growth factor beta2 production,0.01908,
BP,GO:0034085,establishment of sister chromatid cohesion,0.01908,
BP,GO:0043587,tongue morphogenesis,0.01908,
BP,GO:0048102,autophagic cell death,0.01908,
BP,GO:0051683,establishment of Golgi localization,0.01908,
BP,GO:0060056,mammary gland involution,0.01908,
BP,GO:0060355,positive regulation of cell adhesion molecule production,0.01908,
BP,GO:0071476,cellular hypotonic response,0.01908,
BP,GO:0072161,mesenchymal cell differentiation involved in kidney development,0.01908,
BP,GO:0072239,metanephric glomerulus vasculature development,0.01908,
BP,GO:0098909,regulation of cardiac muscle cell action potential involved in regulation of contraction,0.01908,
BP,GO:1903361,protein localization to basolateral plasma membrane,0.01908,
BP,GO:1903961,positive regulation of anion transmembrane transport,0.01908,
BP,GO:1904238,pericyte cell differentiation,0.01908,
BP,GO:2000288,positive regulation of myoblast proliferation,0.01908,
BP,GO:2001012,mesenchymal cell differentiation involved in renal system development,0.01908,
BP,GO:2001016,positive regulation of skeletal muscle cell differentiation,0.01908,
BP,GO:0002444,myeloid leukocyte mediated immunity,0.01914,
BP,GO:0007517,muscle organ development,0.01931,
BP,GO:0042475,odontogenesis of dentin-containing tooth,0.01983,
BP,GO:1902036,regulation of hematopoietic stem cell differentiation,0.01983,
BP,GO:0032270,positive regulation of cellular protein metabolic process,0.01986,
BP,GO:0007015,actin filament organization,0.01991,
BP,GO:0097190,apoptotic signaling pathway,0.01996,
BP,GO:0010033,response to organic substance,0.02015,
BP,GO:0006402,mRNA catabolic process,0.02021,
BP,GO:0048644,muscle organ morphogenesis,0.02024,
BP,GO:0031669,cellular response to nutrient levels,0.02039,
BP,GO:0034249,negative regulation of cellular amide metabolic process,0.02039,
BP,GO:0045595,regulation of cell differentiation,0.0206,
BP,GO:0045444,fat cell differentiation,0.02062,
BP,GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,0.02066,
BP,GO:0051492,regulation of stress fiber assembly,0.02066,
BP,GO:0036294,cellular response to decreased oxygen levels,0.02084,
BP,GO:0048705,skeletal system morphogenesis,0.02106,
BP,GO:0060021,roof of mouth development,0.02108,
BP,GO:0006072,glycerol-3-phosphate metabolic process,0.02144,
BP,GO:0010359,regulation of anion channel activity,0.02144,
BP,GO:0010760,negative regulation of macrophage chemotaxis,0.02144,
BP,GO:0019673,GDP-mannose metabolic process,0.02144,
BP,GO:0036490,regulation of translation in response to endoplasmic reticulum stress,0.02144,
BP,GO:0042473,outer ear morphogenesis,0.02144,
BP,GO:0042748,"circadian sleep/wake cycle, non-REM sleep",0.02144,
BP,GO:0043379,memory T cell differentiation,0.02144,
BP,GO:0044828,negative regulation by host of viral genome replication,0.02144,
BP,GO:0048149,behavioral response to ethanol,0.02144,
BP,GO:0048793,pronephros development,0.02144,
BP,GO:0060013,righting reflex,0.02144,
BP,GO:0060023,soft palate development,0.02144,
BP,GO:0060586,multicellular organismal iron ion homeostasis,0.02144,
BP,GO:0060872,semicircular canal development,0.02144,
BP,GO:0060982,coronary artery morphogenesis,0.02144,
BP,GO:0061004,pattern specification involved in kidney development,0.02144,
BP,GO:0070417,cellular response to cold,0.02144,
BP,GO:0072048,renal system pattern specification,0.02144,
BP,GO:0072172,mesonephric tubule formation,0.02144,
BP,GO:0072177,mesonephric duct development,0.02144,
BP,GO:0090237,regulation of arachidonic acid secretion,0.02144,
BP,GO:0090527,actin filament reorganization,0.02144,
BP,GO:0090649,response to oxygen-glucose deprivation,0.02144,
BP,GO:0090650,cellular response to oxygen-glucose deprivation,0.02144,
BP,GO:0090715,immunological memory formation process,0.02144,
BP,GO:1901844,regulation of cell communication by electrical coupling involved in cardiac conduction,0.02144,
BP,GO:1903069,regulation of ER-associated ubiquitin-dependent protein catabolic process,0.02144,
BP,GO:1901379,regulation of potassium ion transmembrane transport,0.02151,
BP,GO:1900407,regulation of cellular response to oxidative stress,0.02194,
BP,GO:0006469,negative regulation of protein kinase activity,0.02197,
BP,GO:0044255,cellular lipid metabolic process,0.02212,
BP,GO:0016567,protein ubiquitination,0.02234,
BP,GO:2001021,negative regulation of response to DNA damage stimulus,0.02237,
BP,GO:0019538,protein metabolic process,0.02252,
BP,GO:0044770,cell cycle phase transition,0.02278,
BP,GO:0048704,embryonic skeletal system morphogenesis,0.02281,
BP,GO:0061097,regulation of protein tyrosine kinase activity,0.02281,
BP,GO:0061418,regulation of transcription from RNA polymerase II promoter in response to hypoxia,0.02281,
BP,GO:0090559,regulation of membrane permeability,0.02281,
BP,GO:1901700,response to oxygen-containing compound,0.02295,
BP,GO:0006813,potassium ion transport,0.02313,
BP,GO:1905897,regulation of response to endoplasmic reticulum stress,0.02325,
BP,GO:0032092,positive regulation of protein binding,0.02369,
BP,GO:0003376,sphingosine-1-phosphate receptor signaling pathway,0.02379,
BP,GO:0006013,mannose metabolic process,0.02379,
BP,GO:0006222,UMP biosynthetic process,0.02379,
BP,GO:0006971,hypotonic response,0.02379,
BP,GO:0007614,short-term memory,0.02379,
BP,GO:0008343,adult feeding behavior,0.02379,
BP,GO:0009173,pyrimidine ribonucleoside monophosphate metabolic process,0.02379,
BP,GO:0009174,pyrimidine ribonucleoside monophosphate biosynthetic process,0.02379,
BP,GO:0009414,response to water deprivation,0.02379,
BP,GO:0010998,regulation of translational initiation by eIF2 alpha phosphorylation,0.02379,
BP,GO:0033483,gas homeostasis,0.02379,
BP,GO:0042428,serotonin metabolic process,0.02379,
BP,GO:0045792,negative regulation of cell size,0.02379,
BP,GO:0046049,UMP metabolic process,0.02379,
BP,GO:0052646,alditol phosphate metabolic process,0.02379,
BP,GO:0072203,cell proliferation involved in metanephros development,0.02379,
BP,GO:1903789,regulation of amino acid transmembrane transport,0.02379,
BP,GO:2001054,negative regulation of mesenchymal cell apoptotic process,0.02379,
BP,GO:2001225,regulation of chloride transport,0.02379,
BP,GO:0031532,actin cytoskeleton reorganization,0.02414,
BP,GO:0060218,hematopoietic stem cell differentiation,0.02414,
BP,GO:0051701,interaction with host,0.02457,
BP,GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,0.02459,
BP,GO:0031145,anaphase-promoting complex-dependent catabolic process,0.02459,
BP,GO:0120035,regulation of plasma membrane bounded cell projection organization,0.02463,
BP,GO:0071702,organic substance transport,0.02476,
BP,GO:0010562,positive regulation of phosphorus metabolic process,0.02478,
BP,GO:0045937,positive regulation of phosphate metabolic process,0.02478,
BP,GO:0007267,cell-cell signaling,0.02482,
BP,GO:0061061,muscle structure development,0.0249,
BP,GO:0030036,actin cytoskeleton organization,0.02544,
BP,GO:0033238,regulation of cellular amine metabolic process,0.0255,
BP,GO:0110020,regulation of actomyosin structure organization,0.0255,
BP,GO:1901532,regulation of hematopoietic progenitor cell differentiation,0.0255,
BP,GO:1901888,regulation of cell junction assembly,0.0255,
BP,GO:0032269,negative regulation of cellular protein metabolic process,0.02558,
BP,GO:0006401,RNA catabolic process,0.02579,
BP,GO:0003007,heart morphogenesis,0.02581,
BP,GO:0070647,protein modification by small protein conjugation or removal,0.02598,
BP,GO:0031344,regulation of cell projection organization,0.026,
BP,GO:0002903,negative regulation of B cell apoptotic process,0.02614,
BP,GO:0016264,gap junction assembly,0.02614,
BP,GO:0032308,positive regulation of prostaglandin secretion,0.02614,
BP,GO:0034141,positive regulation of toll-like receptor 3 signaling pathway,0.02614,
BP,GO:0035542,regulation of SNARE complex assembly,0.02614,
BP,GO:0035627,ceramide transport,0.02614,
BP,GO:0043097,pyrimidine nucleoside salvage,0.02614,
BP,GO:0044854,plasma membrane raft assembly,0.02614,
BP,GO:0048548,regulation of pinocytosis,0.02614,
BP,GO:0060272,embryonic skeletal joint morphogenesis,0.02614,
BP,GO:0072584,caveolin-mediated endocytosis,0.02614,
BP,GO:0099149,regulation of postsynaptic neurotransmitter receptor internalization,0.02614,
BP,GO:1902882,regulation of response to oxidative stress,0.02642,
BP,GO:1904029,regulation of cyclin-dependent protein kinase activity,0.02642,
BP,GO:0032231,regulation of actin filament bundle assembly,0.02689,
BP,GO:0046928,regulation of neurotransmitter secretion,0.02689,
BP,GO:0042180,cellular ketone metabolic process,0.02733,
BP,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,0.02733,
BP,GO:0035239,tube morphogenesis,0.02733,
BP,GO:0006996,organelle organization,0.02735,
BP,GO:0030038,contractile actin filament bundle assembly,0.02736,
BP,GO:0043149,stress fiber assembly,0.02736,
BP,GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,0.02736,
BP,GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,0.02736,
BP,GO:0033673,negative regulation of kinase activity,0.02759,
BP,GO:0006641,triglyceride metabolic process,0.02784,
BP,GO:0006672,ceramide metabolic process,0.02784,
BP,GO:0043085,positive regulation of catalytic activity,0.02786,
BP,GO:0031668,cellular response to extracellular stimulus,0.02811,
BP,GO:0043266,regulation of potassium ion transport,0.02831,
BP,GO:0060079,excitatory postsynaptic potential,0.02831,
BP,GO:0006983,ER overload response,0.02849,
BP,GO:0008655,pyrimidine-containing compound salvage,0.02849,
BP,GO:0010649,regulation of cell communication by electrical coupling,0.02849,
BP,GO:0010739,positive regulation of protein kinase A signaling,0.02849,
BP,GO:0032306,regulation of prostaglandin secretion,0.02849,
BP,GO:0034086,maintenance of sister chromatid cohesion,0.02849,
BP,GO:0034088,maintenance of mitotic sister chromatid cohesion,0.02849,
BP,GO:0042532,negative regulation of tyrosine phosphorylation of STAT protein,0.02849,
BP,GO:0044793,negative regulation by host of viral process,0.02849,
BP,GO:0048251,elastic fiber assembly,0.02849,
BP,GO:0048703,embryonic viscerocranium morphogenesis,0.02849,
BP,GO:0051956,negative regulation of amino acid transport,0.02849,
BP,GO:0060353,regulation of cell adhesion molecule production,0.02849,
BP,GO:0090394,negative regulation of excitatory postsynaptic potential,0.02849,
BP,GO:0090520,sphingolipid mediated signaling pathway,0.02849,
BP,GO:1903044,protein localization to membrane raft,0.02849,
BP,GO:2000650,negative regulation of sodium ion transmembrane transporter activity,0.02849,
BP,GO:2001053,regulation of mesenchymal cell apoptotic process,0.02849,
BP,GO:0048731,system development,0.02868,
BP,GO:0051247,positive regulation of protein metabolic process,0.02906,
BP,GO:0097435,supramolecular fiber organization,0.0292,
BP,GO:0009057,macromolecule catabolic process,0.02952,
BP,GO:0044249,cellular biosynthetic process,0.02987,
BP,GO:0033138,positive regulation of peptidyl-serine phosphorylation,0.03026,
BP,GO:0006807,nitrogen compound metabolic process,0.03039,
BP,GO:1901990,regulation of mitotic cell cycle phase transition,0.03043,
BP,GO:0048646,anatomical structure formation involved in morphogenesis,0.03063,
BP,GO:0010972,negative regulation of G2/M transition of mitotic cell cycle,0.03075,
BP,GO:0030148,sphingolipid biosynthetic process,0.03075,
BP,GO:0030241,skeletal muscle myosin thick filament assembly,0.03082,
BP,GO:0031953,negative regulation of protein autophosphorylation,0.03082,
BP,GO:0034139,regulation of toll-like receptor 3 signaling pathway,0.03082,
BP,GO:0044857,plasma membrane raft organization,0.03082,
BP,GO:0047484,regulation of response to osmotic stress,0.03082,
BP,GO:0051001,negative regulation of nitric-oxide synthase activity,0.03082,
BP,GO:0071688,striated muscle myosin thick filament assembly,0.03082,
BP,GO:0072178,nephric duct morphogenesis,0.03082,
BP,GO:0090713,immunological memory process,0.03082,
BP,GO:0097152,mesenchymal cell apoptotic process,0.03082,
BP,GO:0098903,regulation of membrane repolarization during action potential,0.03082,
BP,GO:1901160,primary amino compound metabolic process,0.03082,
BP,GO:1902306,negative regulation of sodium ion transmembrane transport,0.03082,
BP,GO:1903960,negative regulation of anion transmembrane transport,0.03082,
BP,GO:2000543,positive regulation of gastrulation,0.03082,
BP,GO:0034765,regulation of ion transmembrane transport,0.03102,
BP,GO:0007041,lysosomal transport,0.03125,
BP,GO:0017158,regulation of calcium ion-dependent exocytosis,0.03125,
BP,GO:0043269,regulation of ion transport,0.03135,
BP,GO:0006915,apoptotic process,0.03167,
BP,GO:0030282,bone mineralization,0.03175,
BP,GO:0043270,positive regulation of ion transport,0.03192,
BP,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,0.03225,
BP,GO:0099565,"chemical synaptic transmission, postsynaptic",0.03225,
BP,GO:0032446,protein modification by small protein conjugation,0.03234,
BP,GO:0043066,negative regulation of apoptotic process,0.03247,
BP,GO:0007268,chemical synaptic transmission,0.03312,
BP,GO:0098916,anterograde trans-synaptic signaling,0.03312,
BP,GO:0009056,catabolic process,0.03316,
BP,GO:0006241,CTP biosynthetic process,0.03316,
BP,GO:0031034,myosin filament assembly,0.03316,
BP,GO:0036295,cellular response to increased oxygen levels,0.03316,
BP,GO:0038166,angiotensin-activated signaling pathway,0.03316,
BP,GO:0043558,regulation of translational initiation in response to stress,0.03316,
BP,GO:0046036,CTP metabolic process,0.03316,
BP,GO:0048308,organelle inheritance,0.03316,
BP,GO:0048313,Golgi inheritance,0.03316,
BP,GO:0051645,Golgi localization,0.03316,
BP,GO:0060352,cell adhesion molecule production,0.03316,
BP,GO:0071287,cellular response to manganese ion,0.03316,
BP,GO:0072182,regulation of nephron tubule epithelial cell differentiation,0.03316,
BP,GO:0072498,embryonic skeletal joint development,0.03316,
BP,GO:0090128,regulation of synapse maturation,0.03316,
BP,GO:1905522,negative regulation of macrophage migration,0.03316,
BP,GO:0007346,regulation of mitotic cell cycle,0.03328,
BP,GO:0031667,response to nutrient levels,0.03344,
BP,GO:0048519,negative regulation of biological process,0.03374,
BP,GO:0010811,positive regulation of cell-substrate adhesion,0.03378,
BP,GO:0070498,interleukin-1-mediated signaling pathway,0.03378,
BP,GO:0042221,response to chemical,0.03378,
BP,GO:0052547,regulation of peptidase activity,0.03385,
BP,GO:0007166,cell surface receptor signaling pathway,0.03409,
BP,GO:0044087,regulation of cellular component biogenesis,0.03427,
BP,GO:0070252,actin-mediated cell contraction,0.0343,
BP,GO:0051248,negative regulation of protein metabolic process,0.03431,
BP,GO:0045892,"negative regulation of transcription, DNA-templated",0.03443,
BP,GO:0015031,protein transport,0.03458,
BP,GO:0080134,regulation of response to stress,0.0347,
BP,GO:0099537,trans-synaptic signaling,0.03478,
BP,GO:0018107,peptidyl-threonine phosphorylation,0.03482,
BP,GO:0031325,positive regulation of cellular metabolic process,0.03484,
BP,GO:0016049,cell growth,0.0349,
BP,GO:1901576,organic substance biosynthetic process,0.03495,
BP,GO:0006664,glycolipid metabolic process,0.03534,
BP,GO:0016079,synaptic vesicle exocytosis,0.03534,
BP,GO:0035556,intracellular signal transduction,0.03534,
BP,GO:0001574,ganglioside biosynthetic process,0.03548,
BP,GO:0007512,adult heart development,0.03548,
BP,GO:0009209,pyrimidine ribonucleoside triphosphate biosynthetic process,0.03548,
BP,GO:0030240,skeletal muscle thin filament assembly,0.03548,
BP,GO:0031033,myosin filament organization,0.03548,
BP,GO:0032310,prostaglandin secretion,0.03548,
BP,GO:0035635,entry of bacterium into host cell,0.03548,
BP,GO:0043248,proteasome assembly,0.03548,
BP,GO:0044794,positive regulation by host of viral process,0.03548,
BP,GO:0072075,metanephric mesenchyme development,0.03548,
BP,GO:2000343,positive regulation of chemokine (C-X-C motif) ligand 2 production,0.03548,
BP,GO:0051239,regulation of multicellular organismal process,0.03567,
BP,GO:0051348,negative regulation of transferase activity,0.03568,
BP,GO:0099536,synaptic signaling,0.0358,
BP,GO:0031401,positive regulation of protein modification process,0.03581,
BP,GO:0007613,memory,0.03586,
BP,GO:1901800,positive regulation of proteasomal protein catabolic process,0.03586,
BP,GO:1903509,liposaccharide metabolic process,0.03586,
BP,GO:0010941,regulation of cell death,0.03625,
BP,GO:0043069,negative regulation of programmed cell death,0.03629,
BP,GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,0.03639,
BP,GO:0030163,protein catabolic process,0.03643,
BP,GO:1902750,negative regulation of cell cycle G2/M phase transition,0.03692,
BP,GO:0042471,ear morphogenesis,0.03746,
BP,GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,0.03746,
BP,GO:0060828,regulation of canonical Wnt signaling pathway,0.03749,
BP,GO:0000165,MAPK cascade,0.03762,
BP,GO:0002274,myeloid leukocyte activation,0.03772,
BP,GO:0051146,striated muscle cell differentiation,0.0378,
BP,GO:0001765,membrane raft assembly,0.0378,
BP,GO:0006491,N-glycan processing,0.0378,
BP,GO:0009130,pyrimidine nucleoside monophosphate biosynthetic process,0.0378,
BP,GO:0009208,pyrimidine ribonucleoside triphosphate metabolic process,0.0378,
BP,GO:0043173,nucleotide salvage,0.0378,
BP,GO:0043174,nucleoside salvage,0.0378,
BP,GO:0043518,"negative regulation of DNA damage response, signal transduction by p53 class mediator",0.0378,
BP,GO:0072160,nephron tubule epithelial cell differentiation,0.0378,
BP,GO:0072189,ureter development,0.0378,
BP,GO:0072224,metanephric glomerulus development,0.0378,
BP,GO:1902188,positive regulation of viral release from host cell,0.0378,
BP,GO:1901987,regulation of cell cycle phase transition,0.03794,
BP,GO:0015833,peptide transport,0.03859,
BP,GO:0090066,regulation of anatomical structure size,0.03906,
BP,GO:0001838,embryonic epithelial tube formation,0.03908,
BP,GO:0018210,peptidyl-threonine modification,0.03908,
BP,GO:0008610,lipid biosynthetic process,0.03915,
BP,GO:0042552,myelination,0.03962,
BP,GO:0002902,regulation of B cell apoptotic process,0.04012,
BP,GO:0007076,mitotic chromosome condensation,0.04012,
BP,GO:0007379,segment specification,0.04012,
BP,GO:0009129,pyrimidine nucleoside monophosphate metabolic process,0.04012,
BP,GO:0009415,response to water,0.04012,
BP,GO:0021783,preganglionic parasympathetic fiber development,0.04012,
BP,GO:0032305,positive regulation of icosanoid secretion,0.04012,
BP,GO:0033033,negative regulation of myeloid cell apoptotic process,0.04012,
BP,GO:0072176,nephric duct development,0.04012,
BP,GO:0086103,G protein-coupled receptor signaling pathway involved in heart process,0.04012,
BP,GO:0090185,negative regulation of kidney development,0.04012,
BP,GO:2000121,regulation of removal of superoxide radicals,0.04012,
BP,GO:2000811,negative regulation of anoikis,0.04012,
BP,GO:0035270,endocrine system development,0.04017,
BP,GO:0009058,biosynthetic process,0.0405,
BP,GO:0009991,response to extracellular stimulus,0.04066,
BP,GO:0007272,ensheathment of neurons,0.04072,
BP,GO:0008366,axon ensheathment,0.04072,
BP,GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,0.04072,
BP,GO:0001568,blood vessel development,0.04081,
BP,GO:0016579,protein deubiquitination,0.04125,
BP,GO:0008152,metabolic process,0.04164,
BP,GO:1903507,negative regulation of nucleic acid-templated transcription,0.0417,
BP,GO:0046907,intracellular transport,0.04177,
BP,GO:0002223,stimulatory C-type lectin receptor signaling pathway,0.04184,
BP,GO:0019079,viral genome replication,0.04184,
BP,GO:1902679,negative regulation of RNA biosynthetic process,0.04198,
BP,GO:0070887,cellular response to chemical stimulus,0.04237,
BP,GO:0008637,apoptotic mitochondrial changes,0.0424,
BP,GO:0010766,negative regulation of sodium ion transport,0.04243,
BP,GO:0014866,skeletal myofibril assembly,0.04243,
BP,GO:0015732,prostaglandin transport,0.04243,
BP,GO:0032780,negative regulation of ATPase activity,0.04243,
BP,GO:0060977,coronary vasculature morphogenesis,0.04243,
BP,GO:0070166,enamel mineralization,0.04243,
BP,GO:0071428,rRNA-containing ribonucleoprotein complex export from nucleus,0.04243,
BP,GO:0098884,postsynaptic neurotransmitter receptor internalization,0.04243,
BP,GO:0140239,postsynaptic endocytosis,0.04243,
BP,GO:1900242,regulation of synaptic vesicle endocytosis,0.04243,
BP,GO:1901550,regulation of endothelial cell development,0.04243,
BP,GO:1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,0.04243,
BP,GO:1903140,regulation of establishment of endothelial barrier,0.04243,
BP,GO:0008284,positive regulation of cell proliferation,0.04261,
BP,GO:0009966,regulation of signal transduction,0.04289,
BP,GO:0006639,acylglycerol metabolic process,0.04296,
BP,GO:0055007,cardiac muscle cell differentiation,0.04296,
BP,GO:2000736,regulation of stem cell differentiation,0.04296,
BP,GO:0006638,neutral lipid metabolic process,0.04353,
BP,GO:0072175,epithelial tube formation,0.04353,
BP,GO:0051050,positive regulation of transport,0.04359,
BP,GO:1902807,negative regulation of cell cycle G1/S phase transition,0.0441,
BP,GO:0007275,multicellular organism development,0.04438,
BP,GO:0009148,pyrimidine nucleoside triphosphate biosynthetic process,0.04474,
BP,GO:0035493,SNARE complex assembly,0.04474,
BP,GO:0035994,response to muscle stretch,0.04474,
BP,GO:0042693,muscle cell fate commitment,0.04474,
BP,GO:0044827,modulation by host of viral genome replication,0.04474,
BP,GO:0045947,negative regulation of translational initiation,0.04474,
BP,GO:0048486,parasympathetic nervous system development,0.04474,
BP,GO:0060546,negative regulation of necroptotic process,0.04474,
BP,GO:0061003,positive regulation of dendritic spine morphogenesis,0.04474,
BP,GO:0072074,kidney mesenchyme development,0.04474,
BP,GO:0072079,nephron tubule formation,0.04474,
BP,GO:2000193,positive regulation of fatty acid transport,0.04474,
BP,GO:2000341,regulation of chemokine (C-X-C motif) ligand 2 production,0.04474,
BP,GO:0002220,innate immune response activating cell surface receptor signaling pathway,0.04524,
BP,GO:0007498,mesoderm development,0.04524,
BP,GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,0.04524,
BP,GO:0015672,monovalent inorganic cation transport,0.04544,
BP,GO:0045860,positive regulation of protein kinase activity,0.04569,
BP,GO:0060048,cardiac muscle contraction,0.04582,
BP,GO:1903052,positive regulation of proteolysis involved in cellular protein catabolic process,0.04582,
BP,GO:0002479,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",0.0464,
BP,GO:0070646,protein modification by small protein removal,0.0469,
BP,GO:0032303,regulation of icosanoid secretion,0.04703,
BP,GO:0032769,negative regulation of monooxygenase activity,0.04703,
BP,GO:0043586,tongue development,0.04703,
BP,GO:0045019,negative regulation of nitric oxide biosynthetic process,0.04703,
BP,GO:0048739,cardiac muscle fiber development,0.04703,
BP,GO:0048745,smooth muscle tissue development,0.04703,
BP,GO:0072234,metanephric nephron tubule development,0.04703,
BP,GO:0098911,regulation of ventricular cardiac muscle cell action potential,0.04703,
BP,GO:1903204,negative regulation of oxidative stress-induced neuron death,0.04703,
BP,GO:1904406,negative regulation of nitric oxide metabolic process,0.04703,
BP,GO:2000696,regulation of epithelial cell differentiation involved in kidney development,0.04703,
BP,GO:0008285,negative regulation of cell proliferation,0.04723,
BP,GO:0045184,establishment of protein localization,0.04733,
BP,GO:0001944,vasculature development,0.04764,
BP,GO:0012501,programmed cell death,0.04803,
BP,GO:0006950,response to stress,0.04808,
BP,GO:0030048,actin filament-based movement,0.04816,
BP,GO:0051291,protein heterooligomerization,0.04816,
BP,GO:0009968,negative regulation of signal transduction,0.04866,
BP,GO:0007569,cell aging,0.04875,
BP,GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,0.04875,
BP,GO:0051588,regulation of neurotransmitter transport,0.04875,
BP,GO:0002689,negative regulation of leukocyte chemotaxis,0.04933,
BP,GO:0006907,pinocytosis,0.04933,
BP,GO:0010042,response to manganese ion,0.04933,
BP,GO:0032891,negative regulation of organic acid transport,0.04933,
BP,GO:0036499,PERK-mediated unfolded protein response,0.04933,
BP,GO:0043555,regulation of translation in response to stress,0.04933,
BP,GO:0045603,positive regulation of endothelial cell differentiation,0.04933,
BP,GO:0046132,pyrimidine ribonucleoside biosynthetic process,0.04933,
BP,GO:0050802,"circadian sleep/wake cycle, sleep",0.04933,
BP,GO:0050951,sensory perception of temperature stimulus,0.04933,
BP,GO:0055093,response to hyperoxia,0.04933,
BP,GO:0071636,positive regulation of transforming growth factor beta production,0.04933,
BP,GO:0072087,renal vesicle development,0.04933,
BP,GO:0072111,cell proliferation involved in kidney development,0.04933,
BP,GO:0072567,chemokine (C-X-C motif) ligand 2 production,0.04933,
BP,GO:0097503,sialylation,0.04933,
BP,GO:1902165,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,0.04933,
BP,GO:1903817,negative regulation of voltage-gated potassium channel activity,0.04933,
BP,GO:1904294,positive regulation of ERAD pathway,0.04933,
BP,GO:0033135,regulation of peptidyl-serine phosphorylation,0.04934,
BP,GO:0043618,regulation of transcription from RNA polymerase II promoter in response to stress,0.04934,
BP,GO:0072358,cardiovascular system development,0.04951,
BP,GO:0034097,response to cytokine,0.0496,
BP,GO:0071310,cellular response to organic substance,0.0498,
BP,GO:0007006,mitochondrial membrane organization,0.04994,
BP,GO:0070972,protein localization to endoplasmic reticulum,0.04994,
CC,GO:0030897,HOPS complex,0.0005,
CC,GO:0032116,SMC loading complex,0.00479,
CC,GO:0033596,TSC1-TSC2 complex,0.00479,
CC,GO:0090694,Scc2-Scc4 cohesin loading complex,0.00479,
CC,GO:0097129,cyclin D2-CDK4 complex,0.00479,
CC,GO:1904813,ficolin-1-rich granule lumen,0.00481,
CC,GO:0098559,cytoplasmic side of early endosome membrane,0.00718,
CC,GO:0035577,azurophil granule membrane,0.00885,
CC,GO:0071953,elastic fiber,0.00957,
CC,GO:0098842,postsynaptic early endosome,0.00957,
CC,GO:1902494,catalytic complex,0.01027,
CC,GO:0010009,cytoplasmic side of endosome membrane,0.01194,
CC,GO:0033263,CORVET complex,0.01194,
CC,GO:0070695,FHF complex,0.01194,
CC,GO:0030027,lamellipodium,0.01244,
CC,GO:0031901,early endosome membrane,0.01295,
CC,GO:1990234,transferase complex,0.01567,
CC,GO:0005811,lipid droplet,0.01584,
CC,GO:0099023,tethering complex,0.01584,
CC,GO:0099503,secretory vesicle,0.01603,
CC,GO:0101002,ficolin-1-rich granule,0.0164,
CC,GO:0000502,proteasome complex,0.01815,
CC,GO:0005769,early endosome,0.01825,
CC,GO:1905369,endopeptidase complex,0.01855,
CC,GO:0031252,cell leading edge,0.01882,
CC,GO:0008541,"proteasome regulatory particle, lid subcomplex",0.01904,
CC,GO:0005925,focal adhesion,0.02283,
CC,GO:0005924,cell-substrate adherens junction,0.02333,
CC,GO:0034098,VCP-NPL4-UFD1 AAA ATPase complex,0.02375,
CC,GO:0030055,cell-substrate junction,0.024,
CC,GO:0030141,secretory granule,0.02507,
CC,GO:0005829,cytosol,0.02523,
CC,GO:1902554,serine/threonine protein kinase complex,0.02543,
CC,GO:0030123,AP-3 adaptor complex,0.02609,
CC,GO:0005884,actin filament,0.02823,
CC,GO:0032009,early phagosome,0.02843,
CC,GO:1905368,peptidase complex,0.02871,
CC,GO:0042470,melanosome,0.03266,
CC,GO:0048770,pigment granule,0.03266,
CC,GO:0098845,postsynaptic endosome,0.03309,
CC,GO:1902911,protein kinase complex,0.03523,
CC,GO:0098993,anchored component of synaptic vesicle membrane,0.03541,
CC,GO:0015629,actin cytoskeleton,0.03652,
CC,GO:0000151,ubiquitin ligase complex,0.03737,
CC,GO:0016581,NuRD complex,0.03773,
CC,GO:0090545,CHD-type complex,0.03773,
CC,GO:0035098,ESC/E(Z) complex,0.04004,
CC,GO:0005938,cell cortex,0.04177,
CC,GO:0031982,vesicle,0.04195,
CC,GO:1990111,spermatoproteasome complex,0.04464,
CC,GO:0101031,chaperone complex,0.04923,
MF,GO:0016301,kinase activity,0.0003,
MF,GO:0097493,structural molecule activity conferring elasticity,0.00033,
MF,GO:0004861,cyclin-dependent protein serine/threonine kinase inhibitor activity,0.00046,
MF,GO:0019900,kinase binding,0.00049,
MF,GO:0016772,"transferase activity, transferring phosphorus-containing groups",0.00104,
MF,GO:0019901,protein kinase binding,0.00127,
MF,GO:0070320,inward rectifier potassium channel inhibitor activity,0.00248,
MF,GO:0099038,ceramide-translocating ATPase activity,0.00248,
MF,GO:0102773,dihydroceramide kinase activity,0.00248,
MF,GO:0030291,protein serine/threonine kinase inhibitor activity,0.0032,
MF,GO:0019899,enzyme binding,0.00413,
MF,GO:0001729,ceramide kinase activity,0.00495,
MF,GO:0004615,phosphomannomutase activity,0.00495,
MF,GO:0033149,FFAT motif binding,0.00495,
MF,GO:0090555,phosphatidylethanolamine-translocating ATPase activity,0.00495,
MF,GO:0051879,Hsp90 protein binding,0.00556,
MF,GO:0016538,cyclin-dependent protein serine/threonine kinase regulator activity,0.0063,
MF,GO:1904121,phosphatidylethanolamine transporter activity,0.00741,
MF,GO:0016740,transferase activity,0.00803,
MF,GO:0004370,glycerol kinase activity,0.00987,
MF,GO:0004694,eukaryotic translation initiation factor 2alpha kinase activity,0.00987,
MF,GO:0004849,uridine kinase activity,0.00987,
MF,GO:0050178,phenylpyruvate tautomerase activity,0.00987,
MF,GO:0090554,phosphatidylcholine-translocating ATPase activity,0.00987,
MF,GO:0000978,RNA polymerase II proximal promoter sequence-specific DNA binding,0.01072,
MF,GO:0045182,translation regulator activity,0.01165,
MF,GO:0000987,proximal promoter sequence-specific DNA binding,0.01188,
MF,GO:0004860,protein kinase inhibitor activity,0.01199,
MF,GO:0001727,lipid kinase activity,0.01232,
MF,GO:0003828,"alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity",0.01232,
MF,GO:0004167,dopachrome isomerase activity,0.01232,
MF,GO:0016862,"intramolecular oxidoreductase activity, interconverting keto- and enol-groups",0.01232,
MF,GO:0003690,double-stranded DNA binding,0.01293,
MF,GO:0019210,kinase inhibitor activity,0.01375,
MF,GO:0019887,protein kinase regulator activity,0.01387,
MF,GO:0042030,ATPase inhibitor activity,0.01477,
MF,GO:0000977,RNA polymerase II regulatory region sequence-specific DNA binding,0.01495,
MF,GO:0001012,RNA polymerase II regulatory region DNA binding,0.01554,
MF,GO:0033613,activating transcription factor binding,0.01679,
MF,GO:0031433,telethonin binding,0.01721,
MF,GO:0005113,patched binding,0.01964,
MF,GO:0008140,cAMP response element binding protein binding,0.01964,
MF,GO:0035620,ceramide transporter activity,0.01964,
MF,GO:0038036,sphingosine-1-phosphate receptor activity,0.01964,
MF,GO:0019207,kinase regulator activity,0.02018,
MF,GO:0000976,transcription regulatory region sequence-specific DNA binding,0.0205,
MF,GO:0019870,potassium channel inhibitor activity,0.02207,
MF,GO:0030023,extracellular matrix constituent conferring elasticity,0.02207,
MF,GO:0005522,profilin binding,0.02449,
MF,GO:0008525,phosphatidylcholine transporter activity,0.02449,
MF,GO:0019206,nucleoside kinase activity,0.02449,
MF,GO:1990837,sequence-specific double-stranded DNA binding,0.02548,
MF,GO:0043565,sequence-specific DNA binding,0.02638,
MF,GO:0016868,"intramolecular transferase activity, phosphotransferases",0.02691,
MF,GO:0033691,sialic acid binding,0.02691,
MF,GO:0000980,RNA polymerase II distal enhancer sequence-specific DNA binding,0.0279,
MF,GO:0005515,protein binding,0.02796,
MF,GO:0046624,sphingolipid transporter activity,0.02932,
MF,GO:0005041,low-density lipoprotein particle receptor activity,0.03172,
MF,GO:0005488,binding,0.03177,
MF,GO:0045125,bioactive lipid receptor activity,0.03412,
MF,GO:0044212,transcription regulatory region DNA binding,0.0364,
MF,GO:0032794,GTPase activating protein binding,0.03651,
MF,GO:0050998,nitric-oxide synthase binding,0.03651,
MF,GO:0001067,regulatory region nucleic acid binding,0.0367,
MF,GO:0047485,protein N-terminus binding,0.03783,
MF,GO:0030228,lipoprotein particle receptor activity,0.0389,
MF,GO:0044325,ion channel binding,0.04064,
MF,GO:0050839,cell adhesion molecule binding,0.04064,
MF,GO:0035497,cAMP response element binding,0.04128,
MF,GO:0051371,muscle alpha-actinin binding,0.04128,
MF,GO:0001158,enhancer sequence-specific DNA binding,0.04178,
MF,GO:0016773,"phosphotransferase activity, alcohol group as acceptor",0.04264,
MF,GO:0005178,integrin binding,0.0447,
MF,GO:0003951,NAD+ kinase activity,0.04603,
MF,GO:0016863,"intramolecular oxidoreductase activity, transposing C=C bonds",0.04603,
MF,GO:0046982,protein heterodimerization activity,0.0471,
MF,GO:0031072,heat shock protein binding,0.04768,
,,,,
,,,,
Table 3 KEGG enrichment results,,,,
classification A,classification B,KEGG ID,pathway,P-value
Cellular Processes,Cell growth and death,ko04110,Cell cycle,0.0048218
Human Diseases,Infectious diseases,ko05169,Epstein-Barr virus infection,0.008727
Genetic Information Processing,"Folding, sorting and degradation",ko03050,Proteasome,0.0127135
Organismal Systems,Aging,ko04211,Longevity regulating pathway - mammal,0.0322073
Human Diseases,Cancers,ko05203,Viral carcinogenesis,0.0323794
Organismal Systems,Endocrine system,ko04928,"Parathyroid hormone synthesis, secretion and action",0.0392567
Environmental Information Processing,Signal transduction,ko04152,AMPK signaling pathway,0.0468405
Metabolism,Amino acid metabolism,ko00360,Phenylalanine metabolism,0.0475716
Cellular Processes,Transport and catabolism,ko04140,Autophagy - animal,0.0494805
,,,,
